Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases

被引:133
作者
Marcotte, Douglas J. [1 ]
Liu, Yu-Ting [1 ]
Arduini, Robert M. [1 ]
Hession, Catherine A. [1 ]
Miatkowski, Konrad [1 ]
Wildes, Craig P. [1 ]
Cullen, Patrick F. [1 ]
Hong, Victor [1 ]
Hopkins, Brian T. [1 ]
Mertsching, Elisabeth [2 ]
Jenkins, Tracy J. [1 ]
Romanowski, Michael J. [3 ]
Baker, Darren P. [1 ]
Silvian, Laura F. [1 ]
机构
[1] Biogen Idec Inc, Cambridge Ctr 12, Drug Discovery Dept, Cambridge, MA 02142 USA
[2] Biogen Idec Inc, San Diego, CA 92122 USA
[3] Sunesis Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
Bruton's tyrosine kinase; BTK; Dasatinib; Celera compound; TEC-family; crystal structure; X-LINKED AGAMMAGLOBULINEMIA; CRYSTAL-STRUCTURES; SELECTIVE INHIBITORS; POTENT INHIBITOR; SRC FAMILY; BTK; LFM-A13; DESIGN; DOMAIN; DASATINIB;
D O I
10.1002/pro.321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bruton's tyrosine kinase (BTK), a member of the TEC family of kinases, plays a crucial role in B-cell maturation and mast cell activation. Although the structures of the unphosphorylated mouse BTK kinase domain and the unphosphorylated and phosphorylated kinase domains of human ITK are known, understanding the kinase selectivity profiles of BTK inhibitors has been hampered by the lack of availability of a high resolution, ligand-bound BTK structure. Here, we report the crystal structures of the human BTK kinase domain bound to either Dasatinib (BMS-354825) at 1.9 angstrom resolution or to 4-amino-5-(4-phenoxyphenyl)-7H-pyrrolospyrimidin-7-yl-cyclopentane at 1.6 angstrom resolution. This data provides information relevant to the development of small molecule inhibitors targeting BTK and the TEC family of nonreceptor tyrosine kinases. Analysis of the structural differences between the TEC and Src families of kinases near the Trp-Glu-Ile motif in the N-terminal region of the kinase domain suggests a mechanism of regulation of the TEC family members.
引用
收藏
页码:429 / 439
页数:11
相关论文
共 30 条
[1]   Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I [J].
Arnold, LD ;
Calderwood, DJ ;
Dixon, RW ;
Johnston, DN ;
Kamens, JS ;
Munschauer, R ;
Rafferty, P ;
Ratnofsky, SE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (19) :2167-2170
[2]   Crystal structures of interleukin-2 tyrosine kinase and their implications for the design of selective inhibitors [J].
Brown, K ;
Long, JM ;
Vial, SCM ;
Dedi, N ;
Dunster, NJ ;
Renwick, SB ;
Tanner, AJ ;
Frantz, JD ;
Fleming, MA ;
Cheetham, GMT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (18) :18727-18732
[3]   Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of Lck [J].
Calderwood, DJ ;
Johnston, DN ;
Munschauer, R ;
Rafferty, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) :1683-1686
[4]   Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases [J].
Carter, TA ;
Wodicka, LM ;
Shah, NP ;
Velasco, AM ;
Fabian, MA ;
Treiber, DK ;
Milanov, ZV ;
Atteridge, CE ;
Biggs, WH ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Mehta, SA ;
Patel, HK ;
Pao, W ;
Sawyers, CL ;
Varmus, H ;
Zarrinkar, PP ;
Lockhart, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :11011-11016
[5]   The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation [J].
Cowan-Jacob, SW ;
Fendrich, G ;
Manley, PW ;
Jahnke, W ;
Fabbro, D ;
Liebetanz, J ;
Meyer, T .
STRUCTURE, 2005, 13 (06) :861-871
[6]   Activation mechanism and steady state kinetics of Bruton's tyrosine kinase [J].
Dinh, Marie ;
Grunberger, Dorit ;
Ho, Hoangdung ;
Tsing, Stan Y. ;
Shaw, David ;
Lee, Simon ;
Barnett, Jim ;
Hill, Ronald J. ;
Swinney, David C. ;
Bradshaw, J. Michael .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (12) :8768-8776
[7]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[8]   Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc [J].
Getlik, Matthaeus ;
Gruetter, Christian ;
Simard, Jeffrey R. ;
Klueter, Sabine ;
Rabiller, Matthias ;
Rode, Haridas B. ;
Robubi, Armin ;
Rauh, Daniel .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) :3915-3926
[9]   CALCULATION OF PROTEIN EXTINCTION COEFFICIENTS FROM AMINO-ACID SEQUENCE DATA [J].
GILL, SC ;
VONHIPPEL, PH .
ANALYTICAL BIOCHEMISTRY, 1989, 182 (02) :319-326
[10]   Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families [J].
Guo, SL ;
Wahl, MI ;
Witte, ON .
INTERNATIONAL IMMUNOLOGY, 2006, 18 (01) :79-87